Case File
efta-02579732DOJ Data Set 11OtherEFTA02579732
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02579732
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, January 17, 2014 4:16 PM
To:
Tazia Smith
Subject:
Re: Trade Idea: Long 3-Month USDCAD KI Call Spread - 1.10 with a 1.13 sold call
knocking-in only if USDCAD trades to 1.17 [I)
i like it .. size ?
On Fri, Jan 17, 2014 at 11:48 AM= Tazia Smith <[email protected] <mailto:[email protected]> wrote:
Classification: Fo= internal use only
Jeffrey -
Our US FX traders agree/like Nav's call here. The 3-month 1.10/1.13 USDCAD, 1.17 knock-in call spread (where
that 1.13 short call only exists if USDCAD goes to 1.17 during the life of the trade) described below is currently offered
-1.1% (Source: DB FX Sales, 1/17/14). Please see the investment thesis below and let us know your thoughts.
Best,
Tazia
Indicative levels only. Subject to market movement. Source: DB Key Client Partners London, as of 1/17/14.
Forwarded =y Tazia Smith/db/dbcom on 01/17/2014 10:35 AM
From:
To:
[email protected] <mailto:kcp-emea@li=t.db.com> , [email protected] <mailto:[email protected]> ,
01/17/2014 07:35 AM
Subject:
I like buying USDCAD calls to=position for further weakness in CAD.
Spot FX is currently 1.095. (II
Classification: For internal use only
I like USDCAD call options to position for further weakness in CAD. Spot FX is currently 1.095.
Over the course of the past week the interest rate curve has started pricin= in a small amount of rate cuts - this
development is significant and clearly a beginning of a pain trade. I believe it can go further. Lower CAD rates from here
will drive USD CAD higher.
EFTA_R1_01754813
EFTA02579732
The limited downside play I like best in USDCAD is buying a 3month expiry 1.10 / 1.13 call spread on USDCAD but
where the short 1.13 call position only exists (knocks-in) if USD trades at 1.17 trades in the market before the option
expires, otherwise the option payoff is the same as a 1.10 call option.
It costs 1% of USD notional. I believe the buyer is well compensated for the knock-in component.
If USDCAD rises to 1.15 the option payout is 5 big figures. If 1.17 trades before expiry the payout is limited to 3
big figures.
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
Ne
Y rk NY
Tel
Fa
Mobile
Email tazia.smi
4
tel:%2B1%20%28212%29%20454-2889>
tel:%2B1%20%28646%29%20257-3131>
tel:%2B1%20%28917%29%20327-4107>
com <mailto:[email protected]>
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communicationar> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of thear> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this commun=cation is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01754614
EFTA02579733
Technical Artifacts (11)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Phone
257-3131Phone
2579732Phone
2579733Phone
327-4107Phone
454-2889Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.